198 related articles for article (PubMed ID: 34445198)
1. Evaluation of Interactions of Selected Olivacine Derivatives with DNA and Topoisomerase II.
Tylińska B; Dobosz A; Spychała J; Cwynar-Zając Ł; Czyżnikowska Ż; Kuźniarski A; Gębarowski T
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445198
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human DNA topoisomerase IIα by two novel ellipticine derivatives.
Vann KR; Ergün Y; Zencir S; Oncuoglu S; Osheroff N; Topcu Z
Bioorg Med Chem Lett; 2016 Apr; 26(7):1809-12. PubMed ID: 26906637
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of novel ellipticines as potential anti-cancer agents.
Deane FM; O'Sullivan EC; Maguire AR; Gilbert J; Sakoff JA; McCluskey A; McCarthy FO
Org Biomol Chem; 2013 Feb; 11(8):1334-44. PubMed ID: 23314103
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative activity of some ellipticine-like 11H-pyrido[a]carbazole derivatives.
Ferlin MG; Gia O; Dalla Via L
ChemMedChem; 2011 Oct; 6(10):1872-83. PubMed ID: 21826796
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Human Topoisomerase II by N,N,N-Trimethylethanammonium Iodide Alkylcarbazole Derivatives.
Saturnino C; Caruso A; Iacopetta D; Rosano C; Ceramella J; Muià N; Mariconda A; Bonomo MG; Ponassi M; Rosace G; Sinicropi MS; Longo P
ChemMedChem; 2018 Dec; 13(24):2635-2643. PubMed ID: 30347518
[TBL] [Abstract][Full Text] [Related]
6. Effect of new olivacine derivatives on p53 protein level.
Gębarowski T; Wiatrak B; Gębczak K; Tylińska B; Gąsiorowski K
Pharmacol Rep; 2020 Feb; 72(1):214-224. PubMed ID: 32016852
[TBL] [Abstract][Full Text] [Related]
7. [In vitro stimulation by ellipticine derivatives of DNA cleavage induced by DNA topoisomerase II: a structure-activity relationship].
Fossé P; Charra M; Paoletti C; Saucier JM; René B
Bull Cancer; 1994 Mar; 81(3):194-202. PubMed ID: 7894127
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
El-Adl K; El-Helby AA; Sakr H; Elwan A
Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
[TBL] [Abstract][Full Text] [Related]
9. Cellular resistance to the antitumor DNA topoisomerase II inhibitor S16020-2: importance of the N-[2(Dimethylamino)ethyl]carbamoyl side chain.
Le Mée S; Chaminade F; Delaporte C; Markovits J; Saucier JM; Jacquemin-Sablon A
Mol Pharmacol; 2000 Oct; 58(4):709-18. PubMed ID: 10999940
[TBL] [Abstract][Full Text] [Related]
10. Antitumor Activity of New Olivacine Derivatives.
Piasny J; Wiatrak B; Dobosz A; Tylińska B; Gębarowski T
Molecules; 2020 May; 25(11):. PubMed ID: 32481577
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of naphthalimide-phenanthro[9,10-d]imidazole derivatives: In vitro evaluation, binding interaction with DNA and topoisomerase inhibition.
Singh I; Luxami V; Paul K
Bioorg Chem; 2020 Mar; 96():103631. PubMed ID: 32036164
[TBL] [Abstract][Full Text] [Related]
12. Ellipticines as DNA-targeted chemotherapeutics.
Stiborová M; Frei E
Curr Med Chem; 2014; 21(5):575-91. PubMed ID: 24059226
[TBL] [Abstract][Full Text] [Related]
13. Design, molecular modeling and anticancer evaluation of thieno[2,3-d]pyrimidine derivatives as inhibitors of topoisomerase II.
El-Metwally SA; Khalil AK; El-Sayed WM
Bioorg Chem; 2020 Jan; 94():103492. PubMed ID: 31864673
[TBL] [Abstract][Full Text] [Related]
14. Indenoindolone derivatives as topoisomerase II-inhibiting anticancer agents.
Kashyap M; Kandekar S; Baviskar AT; Das D; Preet R; Mohapatra P; Satapathy SR; Siddharth S; Guchhait SK; Kundu CN; Banerjee UC
Bioorg Med Chem Lett; 2013 Feb; 23(4):934-8. PubMed ID: 23321564
[TBL] [Abstract][Full Text] [Related]
15. Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers.
Abbass EM; Khalil AK; Mohamed MM; Eissa IH; El-Naggar AM
Bioorg Chem; 2020 Nov; 104():104255. PubMed ID: 32927130
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel topoisomerase II alpha inhibitors by virtual screening, molecular docking, and bioassay.
Yu C; Hu J; Luyten W; Sun D; Jiang T
Chem Biol Drug Des; 2022 Jan; 99(1):92-102. PubMed ID: 34310071
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in silico assessment of DNA interaction, topoisomerase I and II inhibition properties of chrysosplenetin.
Şöhretoğlu D; Barut B; Sari S; Özel A; Arroo R
Int J Biol Macromol; 2020 Nov; 163():1053-1059. PubMed ID: 32673727
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid-β-benzyl ester derivatives as potent topoisomerase IIα inhibitors.
Han X; Zhong Y; Zhou G; Qi H; Li S; Ding Q; Liu Z; Song Y; Qiao X
Bioorg Med Chem; 2017 Jun; 25(12):3116-3126. PubMed ID: 28462840
[TBL] [Abstract][Full Text] [Related]
19. N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
Ruckdeschel JC; Modi SP; el-Hamouly W; Portuese E; Archer S
J Med Chem; 1992 Dec; 35(26):4854-7. PubMed ID: 1479585
[TBL] [Abstract][Full Text] [Related]
20. Novel nalidixic acid derivatives targeting topoisomerase II enzyme; Design, synthesis, anticancer activity and effect on cell cycle profile.
Khalil OM; Gedawy EM; El-Malah AA; Adly ME
Bioorg Chem; 2019 Mar; 83():262-276. PubMed ID: 30391699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
